master's thesis
DISCORDANCES IN ER, PR AND HER2NEU RECEPTORS BETWEEN PRIMARY AND METASTATIC BREAST CANCER PATIENTS

Mila Fabris (2016)
University of Split
School of Medicine
Pathology
Cite this document...

Fabris, M. (2016). USPOREDBA HORMONSKOG I HER2 STATUSA U PRIMARNIM I METASTATSKIM KARCINOMIMA DOJKE (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:171:874495

Fabris, Mila. "USPOREDBA HORMONSKOG I HER2 STATUSA U PRIMARNIM I METASTATSKIM KARCINOMIMA DOJKE." Master's thesis, University of Split, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:171:874495

Fabris, Mila. "USPOREDBA HORMONSKOG I HER2 STATUSA U PRIMARNIM I METASTATSKIM KARCINOMIMA DOJKE." Master's thesis, University of Split, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:171:874495

Fabris, M. (2016). 'USPOREDBA HORMONSKOG I HER2 STATUSA U PRIMARNIM I METASTATSKIM KARCINOMIMA DOJKE', Master's thesis, University of Split, School of Medicine, accessed 21 March 2019, https://urn.nsk.hr/urn:nbn:hr:171:874495

Fabris M. USPOREDBA HORMONSKOG I HER2 STATUSA U PRIMARNIM I METASTATSKIM KARCINOMIMA DOJKE [Master's thesis]. Split: University of Split, School of Medicine; 2016 [cited 2019 March 21] Available at: https://urn.nsk.hr/urn:nbn:hr:171:874495

M. Fabris, "USPOREDBA HORMONSKOG I HER2 STATUSA U PRIMARNIM I METASTATSKIM KARCINOMIMA DOJKE", Master's thesis, University of Split, School of Medicine, Split, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:171:874495